NCT06009094View on ClinicalTrials.gov

Safety, Tolerance and Pharmacokinetics Clinical Study of VC005 in Healthy Subjects and Patients with Mild to Moderate Atopic Dermatitis

PHASE1CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

July 27, 2023

Primary Completion Date

May 23, 2024

Study Completion Date

May 23, 2024

Conditions
Atopic Dermatitis
Interventions
DRUG

VC005

VC005 group with Local topical application

DRUG

VC005 Placebo

VC005 Placebo group with Local topical application

Trial Locations (1)

Unknown

Chinese Academy of Medical Sciences Hospital of Skin Disease, Nanjing

All Listed Sponsors
lead

Jiangsu vcare pharmaceutical technology co., LTD

INDUSTRY